WMC WBIRS 2026

World Medical Consortium Conference Node

Call for Submissions Open — WBIRS 2026

World Biomedical Innovation &
Research Summit (WBIRS) 2026

The premier global destination for breakthrough translational medicine, clinical science, and advanced bio-engineering. Empowering the next generation of global medical laureates.

Summit Date

October 12 - 17, 2026

Host Institution

National University of Singapore (NUS)
Learn More 2025 Laureate

What is WBIRS?

An elite academic vehicle driving the future of translocational clinical therapeutics.

The World Biomedical Innovation & Research Summit (WBIRS) is an annual, internationally acclaimed scientific arena orchestrated by the World Medical Consortium (WMC) in structural partnership with leading global healthcare institutions, including the NUS Yong Loo Lin School of Medicine.

The summit serves as a competitive validation node for pioneering research in advanced tissue engineering, cellular therapy, oncology, precision nutrition, and medical AI models. By bringing together the brightest undergraduate, graduate, and doctoral minds alongside veteran clinical investigators, WBIRS accelerates the transition of laboratory breakthroughs into practical, chairside medical solutions.

WBIRS Global Pipeline

Bridging pure academic exploration with real-world clinical re-engineering across continents.

Summit Rigor & Evaluation Pipeline

A highly selective evaluation matrix ensuring the absolute apex of scientific merit.

The Peer-Review Standpoints

Maintaining an uncompromising commitment to academic rigor, WBIRS operates a multi-tiered screening filter. Submissions from academic medical centers worldwide are evaluated by an independent panel using a **double-blind peer review** standard.

Manuscripts are evaluated on clinical viability, biostatistical soundness, and immediate translatability. Finalists selected to deliver an Oral Defense in Singapore are positioned at the absolute forefront of contemporary global health scholarship.

2,400+
Global Submissions
Top 3.3%
Acceptance Rate
20
Nations Represented
80
Elite Finalists

2025 Grand Prize Laureate

Honoring the reigning champion of the WBIRS Scientific Innovation Pitch.

1st Place & Gold Medalist
Zelka Dapala

Zelka Dapala

Universitas Sriwijaya

Indonesia

Reigning Champion (WBIRS 2025)

"3D Bioprinting of Activated Growth Factor (AGF) for Periodontal Alveolar Bone Regeneration"

Abstract Capsule: This breakthrough research proposes a translationally viable methodology using additive manufacturing and precision bio-inks. By integrating Activated Growth Factors (AGF) into 3D bioprinted scaffolds, the study demonstrated a significant 45% acceleration in osteoblast proliferation, providing a patient-specific, highly efficient alternative for alveolar bone defect repair.

Grand Jury Evaluation Consensus: "A stellar presentation exhibiting deep clinical foresight, impeccable methodological soundness, and high potential for chairside translation. An absolute consensus winner."

Historic Finalist Registry

The global roster of innovators representing top tier world universities at the 2025 sessions.

Indonesia 🇮🇩
Zelka Dapala
Universitas Sriwijaya
Indonesia 🇮🇩
Angellita Wijaya G.
Universitas Airlangga
Singapore 🇸🇬
Wei Jie Lee
National University of Singapore
Singapore 🇸🇬
Dylan Tan
National University of Singapore
Japan 🇯🇵
Kenjiro Sato
The University of Tokyo
Japan 🇯🇵
Ayumi Tanaka
Kyoto University
Australia 🇦🇺
Liam O'Connor
University of Melbourne
South Korea 🇰🇷
Min-jun Kim
Seoul National University